Powered by Smartsupp

Adderall XR 20mg


SKU: N/A Category:


Buy Adderall XR 20mg Online – Adderall XR 20mg Oral Tablets For Sale

Buy Adderall XR 20mg Online. Adderall XR is a prescription medicine used to treat the symptoms of narcolepsy and attention deficit hyperactivity disorder (ADHD). Adderall XR may be used alone or with other medications.

What are the possible side effects of Adderall XR?

Adderall XR may cause serious side effects including:

  • chest pain,
  • trouble breathing,
  • lightheadedness,
  • hallucinations,
  • new behavior problems,
  • aggression,
  • hostility,
  • paranoia,
  • numbness,
  • pain,
  • cold feeling,
  • unexplained wounds,
  • skin color changes (pale, red, or blue appearance) in fingers or toes,
  • seizures (convulsions),
  • muscle twitches, and
  • vision changes

Get medical help right away, if you have any of the symptoms listed above. The most common side effects of Adderall XR include:

  • stomach pain,
  • nausea,
  • loss of appetite,
  • weight loss,
  • mood changes,
  • feeling nervous or irritable,
  • fast heart rate,
  • headache,
  • dizziness,
  • sleep problems (insomnia), and
  • dry mouth

Tell the doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of Adderall XR. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.



Amphetamines have a strong misuse potential. A prolonged administration of amphetamines may result in drug dependency. Pay close attention to the risk of patients getting amphetamines for nontherapeutic use or distribution, and prescribe or administer the medicines with caution. Amphetamine abuse may result in sudden mortality and severe cardiovascular side effects.


ADDERALL XR is a once-daily, single-entity, extended-release amphetamine medication. ADDERALL XR combines the dextroamphetamine and amphetamine neutral sulfate salts with the dextro isomer of amphetamine saccharate and d,l-amphetamine aspartate monohydrate. The ADDERALL XR capsule comprises two kinds of drug-containing beads intended to provide a double-pulsed administration of amphetamines, which delays the release of amphetamine from ADDERALL XR relative to the traditional ADDERALL (immediate-release) tablet formulation.


Each capsule contains: 5 mg 10 mg 15 mg 20 mg 25 mg 30 mg
Dextroamphetamine Saccharate 1.25 mg 2.5mg 3.75 mg 5.0 mg 6.25 mg 7.5 mg
Amphetamine Aspartate Monohydrate 1.25 mg 2.5mg 3.75 mg 5.0 mg 6.25 mg 7.5 mg
Dextroamphetamine Sulfate USP 1.25 mg 2.5mg 3.75 mg 5.0 mg 6.25 mg 7.5 mg
Amphetamine Sulfate USP 1.25 mg 2.5mg 3.75 mg 5.0 mg 6.25 mg 7.5 mg
Total amphetamine base equivalence 3.1 mg 6.3mg 9.4 mg 12.5mg 15.6 mg 18.8 mg


Inactive Ingredients and Colors

The inactive ingredients in ADDERALL XR capsules include gelatin capsules, hydroxypropyl methylcellulose, methacrylic acid copolymer, opadry beige, sugar spheres, talc, and triethyl citrate. Gelatin capsules contain edible inks, kosher gelatin, and titanium dioxide. The 5 mg, 10 mg, and 15 mg capsules also contain FD&C Blue #2. The 20 mg, 25 mg, and 30 mg capsules also contain red iron oxide and yellow iron oxide.


Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

Clinical Trials Experience

The ADDERALL XR premarketing development program exposed a total of 1,315 people in clinical studies (635 pediatric patients, 350 adolescent patients, 248 adult patients, and 82 healthy adult subjects). 635 (6-12-year-old) children were investigated in two controlled clinical trials, one open-label clinical study, and two single-dose clinical pharmacology investigations (N=40). All patient safety information is covered in the discussion that follows. To evaluate adverse responses, adverse reactions, results of physical exams, vital signs, weights, laboratory analysis, and ECGs were collected.

Adverse responses during exposure were generally gathered via general inquiry and documented by clinical investigators using their own nomenclature. Therefore, it is impossible to produce a realistic estimate of the percentage of people suffering adverse responses without first categorizing comparable kinds of reactions into a smaller number of standardized event categories. In the tables and lists that follow, adverse responses have been classified using COSTART nomenclature.

The indicated adverse reaction rates reflect the percentage of persons who have had at least one treatment-emergent adverse event of the identified kind.

Adverse Reactions Leading To Discontinuation Of Treatment

In two placebo-controlled studies of up to 5 weeks duration involving children with ADHD, 2.4% (10/425) of ADDERALL XR-treated patients discontinued due to adverse reactions (including 3 patients with appetite loss, one of whom also reported insomnia), compared to 2.7% (7/259) of placebo-treated patients.

In controlled and uncontrolled, multiple-dose clinical studies of children (N=595), the adverse effects leading to termination of ADDERALL XR were anorexia (lack of appetite) (2.9%), sleeplessness (1.5%), weight loss (1.2%), emotional lability (1%) and depression (0.7%). More than half of these patients had been exposed to ADDERALL XR for at least 12 months.

In a separate placebo-controlled 4-week study involving adolescents with ADHD, five patients (2.1%) discontinued treatment due to adverse events among ADDERALL XR-treated patients (N=233), compared to none among placebo-treated patients (N=54). Insomnia (1.3%, n=3) was the most frequent adverse event considered to be drug-related (i.e. leading to discontinuation in at least 1% of ADDERALL XR-treated patients and at a rate at least twice that of placebo).

In a placebo-controlled 4-week research including adults with ADHD at dosages ranging from 20 mg to 60 mg, 23 patients (12.0%) stopped therapy owing to adverse events among ADDERALL XR-treated patients (N=191), compared to one patient (1.6%) who received placebo (N=64). Insomnia (5.2%, n=10), anxiety (2.1%, n=4), nervousness (1.6%, n=3), dry mouth (1.6%, n=3), anorexia (1.6%, n=3), tachycardia (1.6%, n=3), headache (1.6%, n=3), and asthenia (1.0%, n=) were the most frequent adverse events leading to discontinuation that were considered to be drug-related

Adverse Reactions Occurring In Controlled Trials

Adverse reactions reported in a 3-week clinical trial of children and a 4-week clinical trial in adolescents and adults, respectively, treated with ADDERALL XR or placebo are presented in the tables below.

Additional information


60 Pills, 120 Pills, 180 Pills, 240 Pills, 300 Pills


There are no reviews yet.

Be the first to review “Adderall XR 20mg”

Your email address will not be published. Required fields are marked *